Back
Alnylam Pharmaceuticals Stock Price Chart
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
35
ALNY
Alnylam Pharmaceuticals
Last Price:
275.08
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn More- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 273.53 | Buy |
| 20-day SMA: | 264.94 | Buy |
| 50-day SMA: | 262.48 | Buy |
| 200-day SMA: | 194.67 | Buy |
| 8-day EMA: | 272.54 | Buy |
| 20-day EMA: | 269.21 | Buy |
| 50-day EMA: | 257.72 | Buy |
| 200-day EMA: | 211.82 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.58 | Buy |
| Relative Strength Index (14 RSI): | 58.54 | Buy |
| Chaikin Money Flow: | 227264 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (257.28 - 277.8) | Buy |
| Bollinger Bands (100): | (173.47 - 275.75) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 274.91 while ALNY 8-day simple moving average is 273.53, which is a Buy signal.
- The stock price of ALNY is 274.91 while Alnylam Pharmaceuticals 20-day SMA is 264.94, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day simple moving average is 262.48 while ALNY share price is 274.91, making it a Buy technically.
- ALNY stock price is 274.91 and Alnylam Pharmaceuticals 200-day simple moving average is 194.67, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
35.29B
Price in USD:
274.91
Share Volume:
459.53K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
287.55
52-Week Low:
141.98
Sell
35
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 274.91 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 274.91 while ALNY 8-day exponential moving average is 272.54, which is a Buy signal.
- The stock price of ALNY is 274.91 while Alnylam Pharmaceuticals 20-day EMA is 269.21, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day exponential moving average is 257.72 while ALNY share price is 274.91, making it a Buy technically.
- ALNY stock price is 274.91 and Alnylam Pharmaceuticals 200-day simple moving average is 211.82, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is 3.58, suggesting Alnylam Pharmaceuticals is a Buy
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 58.54, which suggest Alnylam Pharmaceuticals is overbought
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (257.28 - 277.8), which suggest Alnylam Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (173.47 - 275.75), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.